ライフサイエンスコーパス: supplemental

1 also that it outperforms the other available supplemental activation methods (ETcaD and EThcD).

2 naesthetics, duration of the block, need for supplemental analgesia, patient and operator satisfactio

3 Supplemental analysis led to similar results when strati

4 We show that both supplemental and ambient magnetic fields modulate myogen

5 e we found that vitamin D intake (from diet, supplemental and total) was not associated with risks of

6 The associations of total (dietary + supplemental) and dietary choline intake with the preval

7 d anesthesia provider satisfaction, need for supplemental anesthesia, and surgical complications.

8 n to perform annual magnetic resonance (with supplemental annual mammography) as an optimal mode of s

9 ssess nutrient intake, including dietary and supplemental B vitamins.

10 Following CMS' 2018 expansion of supplemental benefits available to HMO and PPO Medicare

11 k, during enzymatic hydrolysis of lactose by supplemental beta-galactosidases.

12 We hypothesized that supplemental betaine would protect both the liver and br

13 Excess biotin in blood due to supplemental biotin ingestion may affect biotin-streptav

14 ons of 50 Gy over 5 weeks, with or without a supplemental boost to the tumour bed, and APBI was deliv

15 ogists often influence decisions surrounding supplemental breast cancer screening and risk assessment

16 No supplemental buprenorphine was allowed.

17 Elements were classified as core or supplemental by use of a modified Delphi process.

18 She has been on supplemental calcium gluconate twice daily.

19 These data show that supplemental calcium provided during pregnancy may impro

20 mise in reanalyzing GWAS datasets to provide supplemental candidate loci that are ignored by traditio

21 ancer prognostic prediction and provide more supplemental candidates for the discovery of biomarkers.

22 These results show that supplemental cell-associated antigen enables robust expa

23 ttle to no association of total, dietary, or supplemental choline intake with systolic or diastolic B

24 tors identified from commercial and Medicare supplemental claims databases linked to adjudicated shoc

25 rt representing the general population and 3 supplemental cohorts (with high income, cancer, and with

26 limiting the utility of HIV Ag/Ab Combo and supplemental, confirmatory assays for infection status d

27 The screening and supplemental, confirmatory assays used to identify infec

28 Supplemental, confirmatory testing was performed by the

29 hanced in 3T3 cells grown in the presence of supplemental copper and in cultured Menkes mutant fibrob

30 Because the supplemental diet did not rescue wound healing or nerve

31 nerve densities were not fully rescued by a supplemental diet rich in calcium, lactose, and phosphat

32 Supplemental Digital Content is available in the text

33 Supplemental Digital Content is available in the text.

34 Second, we have introduced a supplemental dipolar AC waveform to the quadrupole mass

35 Supplemental discussion covers emerging topics such as m

36 from the population analysis and guided the supplemental dosing needed.

37 attainment rates were >80% with the proposed supplemental dosing.

38 in the individual articles included in this supplemental edition of the Journal of Infectious Diseas

39 d that prolonged enteral nutrition (EN) with supplemental eicosapentanoic acid (EPA), an omega-3 fatt

40 trophy and atmospheric hydrogen oxidation as supplemental energy sources.

41 se of this study was to model the effects of supplemental EPA + DHA on the O3I.

42 Furthermore, substantial amounts of supplemental EPA can be converted into DHA.

43 regular classroom activities (Figures 1A-1C; Supplemental Experimental Procedures, section S1).

44 Total daily supplemental FA intake was based on self-reported FA-sup

45 ded to maximize the overall effectiveness of supplemental feeding programs (SFPs).We evaluated the ef

46 er species experience greater infection with supplemental feeding.

47 Exogenous supplemental Fgf8 rescues proliferation in Dll4 mutants

48 in the same direction as the original study (Supplemental Figure S7C; Goetz et al., 2011), but not st

49 between conditions, like the original study (Supplemental Figure S7Ca; Goetz et al., 2011).

50 High supplemental folate intake might protect against the adv

51 Supplemental folate intake significantly modified the as

52 Among women with supplemental folate intakes of <800 mug/day, the odds of

53 erved among women consuming >=800 mug/day of supplemental folate.

54 only when they also consumed <800 mug/day of supplemental folate.

55 d) and nearly all took at least 400 mug/d of supplemental folic acid (median, 500; interquartile rang

56 hen adjusted for other covariates, including supplemental folic acid consumption.

57 ight the unintended negative consequences of supplemental folic acid.

58 rished pregnant women receiving ready-to-use supplemental food (RUSF), a fortified corn-soy blend (CS

59 h fresh and PFAS-loaded, was employed as the supplemental fuel supporting smoldering in mixtures with

60 In contrast to WT mice, supplemental glutamine was ineffective in reducing the r

61 Supplemental HMB during fasting periods of TRF did not d

62 orted for these datasets that have value for supplemental hypothesis generation.

63 ovascular, 4) renal and electrolytes, and 5) supplemental ICU topics.

64 ole-cell sonicate (WCS) and a C6 EIA, with a supplemental immunoblot if either EIA was positive or eq

65 We compared CTTT (WCS EIA followed by supplemental immunoblot) to MTTT (WCS EIA followed by C6

66 -tier enzyme immunoassay (EIA) followed by a supplemental immunoblot, and modified two-tiered testing

67 Diagnostic endoscopy provided invaluable supplemental information about the posterior segment in

68 hority reports from 1998 to 2015, and made a supplemental information request to the Oregon Health Au

69 e subspecies has previously been questioned (Supplemental information), and Fennessy and colleagues [

70 tle egg embedded with a GPS-GSM transmitter (Supplemental Information).

71 ial host-plants has been questioned [5] (see Supplemental Information).

72 irmation of the role played by the relative, supplemental information).

73 s into the flesh of the shark (Figure S1C in Supplemental Information, published with this article on

74 h virus-specific CD4CAR T cells, followed by supplemental infusion of cell-associated HIV-1 envelope

75 Dietary and supplemental intake of the omega-3 fatty acid docosahexa

76 se who would benefit from alternative and/or supplemental interventions.

77 d 3 in the intravenous group (7.0%) received supplemental intravenous sedation (difference, 12.1%; 95

78 a water-limited environment with and without supplemental irrigation.

79 scribed in the accompanying articles in this supplemental issue.

80 Supplemental lighting colours did not affect lettuce gro

81 government literature reviews and a de novo supplemental literature review, we compiled and evaluate

82 Supplemental long-chain omega-3 (n-3) fatty acids (EPA a

83 Ambient and supplemental magnetic fields promote myogenesis via a TR

84 Data are needed on the use of supplemental magnetic resonance imaging (MRI) to improve

85 trials document coronary risk reduction from supplemental marine n-3 FAs but no clear CVD risk reduct

86 The supplemental material contains a wide range of simulatio

87 Supplemental Material detailing the underlying algorithm

88 (C) RSNA, 2020 Online supplemental material in available for this article.

89 (C) RSNA, 2018 Online supplemental material is available for this article .

90 Oncology, Treatment Effects, Tumor Response Supplemental material is available for this article.

91 omen/GI, Genetic Defects, Oncology, Pancreas Supplemental material is available for this article.

92 (C) RSNA, 2020 Supplemental material is available for this article.

93 (C) RSNA, 2021 Online supplemental material is available for this article.

94 (C) RSNA, 2018 Online supplemental material is available for this article.

95 (C)RSNA, 2019 Online supplemental material is available for this article.

96 Data System guidelines.(C) RSNA, 2019Online supplemental material is available for this article.

97 d the risk of mortality.(C) RSNA, 2019Online supplemental material is available for this article.

98 ed with methylphenidate.(C) RSNA, 2019Online supplemental material is available for this article.

99 lesion characterization.(C) RSNA, 2019Online supplemental material is available for this article.

100 NCT02143102 ((c)) RSNA, 2017 Online supplemental material is available for this article.

101 Supplemental material is available for this article.

102 (C) RSNA, 2019 Online supplemental material is available for this article.

103 (C) RSNA, 2020 Online supplemental material is available for this article.

104 s are suitable for functional image analysis.Supplemental material is available for this article.(C)

105 itivity of RFs to differences in acquisition.Supplemental material is available for this article.(C)

106 CT images from patients with SSc-related ILD.Supplemental material is available for this article.(C)

107 logic cohort studies with the proposed DCNet.Supplemental material is available for this article.(C)

108 using substantially larger training datasets.Supplemental material is available for this article.(C)

109 CT scans as well as scans demonstrating iNPH.Supplemental material is available for this article.(C)

110 d may suggest an underlying vascular process.Supplemental material is available for this article.(C)

111 ure up to a resolution of 1280 x 1024 pixels.Supplemental material is available for this article.(C)

112 the extensive resources used to perform them.Supplemental material is available for this article.(C)

113 ients who are sensitive to radiation from CT.Supplemental material is available for this article.(C)

114 CLD and patients without airway obstruction.Supplemental material is available for this article.(C)

115 ly comparing different reconstructed volumes.Supplemental material is available for this article.(C)

116 gnosis and treatment of neurologic disorders.Supplemental material is available for this article.(C)

117 oach by homogenizing the content in the MIPs.Supplemental material is available for this article.(C)

118 ers for surveillance and risk stratification.Supplemental material is available for this article.(C)

119 using the MOLLI T1 mapping sequence at 1.5 T.Supplemental material is available for this article.(C)

120 ncy, particularly in severe MV regurgitation.Supplemental material is available for this article.(C)

121 cal information improves outcome predictions.Supplemental material is available for this article.(C)

122 th comprehensive noninvasive CAD diagnostics.Supplemental material is available for this article.(C)

123 ty was acceptable at both anatomic locations.Supplemental material is available for this article.(C)

124 to enhance and accelerate clinical workflows.Supplemental material is available for this article.(C)

125 performing inter- and intraobserver analyses.Supplemental material is available for this article.(C)

126 y of using this approach to estimate E/E (m).Supplemental material is available for this article.(C)

127 in the first months of the COVID-19 pandemic.Supplemental material is available for this article.(C)

128 eaflet perforation, and paravalvular leakage.Supplemental material is available for this article.(C)

129 emonstrated a favorable acute safety profile.Supplemental material is available for this article.(C)

130 e assessment in modern pediatric populations.Supplemental material is available for this article.(C)

131 and negative for pneumonia is nonnegligible.Supplemental material is available for this article.(C)

132 l splenic volumes and splenic volume changes.Supplemental material is available for this article.(C)

133 ast cancer without prolonging their workflow.Supplemental material is available for this article.(C)

134 els for preoperative detection of MVI in HCC.Supplemental material is available for this article.(C)

135 cing the training set with synthetic lesions.Supplemental material is available for this article.(C)

136 ided fellowship-trained attending physicians.Supplemental material is available for this article.(C)

137 decision making for common and rare diseases.Supplemental material is available for this article.(C)

138 fy patients in terms of PE risk and severity.Supplemental material is available for this article.(C)

139 pathophysiologic drivers in lethal COVID-19.Supplemental material is available for this article.(C)

140 lacking in the AJCC clinical staging of MPM.Supplemental material is available for this article.(C)

141 optimized before initiation of immunotherapy.Supplemental material is available for this article.(C)

142 M images and improved by using few SM images.Supplemental material is available for this article.Publ

143 model based on public and site-specific data.Supplemental material is available for this article.Publ

144 00 per life-year gained.(C) RSNA, 2020Online supplemental material is available for this article.See

145 ements in public datasets and trained models.Supplemental material is available for this article.See

146 with symptomatic status.(C) RSNA, 2020Online supplemental material is available for this article.See

147 in the plantar flexors.(C) RSNA, 2020Online supplemental material is available for this article.See

148 PVR prediction in noninvasive PH evaluation.Supplemental material is available for this article.See

149 s at hospital discharge.(C) RSNA, 2019Online supplemental material is available for this article.See

150 cardial T1 or T2 values.(C) RSNA, 2019Online supplemental material is available for this article.See

151 pregnancy is recognized.(C) RSNA, 2019Online supplemental material is available for this article.See

152 lation HCC tumor growth.(C) RSNA, 2019Online supplemental material is available for this article.See

153 extremely dense breasts.(C) RSNA, 2019Online supplemental material is available for this article.See

154 women with average risk.(C) RSNA, 2019Online supplemental material is available for this article.See

155 the superior vena cava.(C) RSNA, 2019Online supplemental material is available for this article.See

156 proportion of the brain.(C) RSNA, 2019Online supplemental material is available for this article.See

157 t tomosynthesis imaging.(C) RSNA, 2020Online supplemental material is available for this article.See

158 set images are provided.(C) RSNA, 2019Online supplemental material is available for this article.See

159 exacerbation risk in adult patients with CF.Supplemental material is available for this article.See

160 for reading this review can be found in the Supplemental Material.

161 ere and all other responses are found in the supplemental material.

162 t platelet function represents a continuous, supplemental mechanism of immune evasion co-opted by tum

163 raphy to a group that was invited to undergo supplemental MRI or to a group that received mammography

164 The use of supplemental MRI screening in women with extremely dense

165 Supplemental n-3 FAs did not significantly reduce the pr

166 Conversely, we found that supplemental NH(4)Cl significantly increases the intrace

167 exhibits marked growth and yield response to supplemental nitrogen (N).

168 The Supplemental Nutrition Assistance Program (SNAP) expande

169 The US Department of Agriculture (USDA) Supplemental Nutrition Assistance Program (SNAP) is the

170 subsidise F&Vs to reduce prices by 30% among Supplemental Nutrition Assistance Program (SNAP) partici

171 observed a trend toward a lower HEI-2010 in Supplemental Nutrition Assistance Program (SNAP) partici

172 (age, race/ethnicity, education, income, and Supplemental Nutrition Assistant Program [SNAP] status).

173 using oxygenated packed red blood cells and supplemental nutrition for a period of 3 hours.

174 r, in an area with prevalent undernutrition, supplemental nutrition offered to pregnant women and the

175 the program's inception in 1974, the Special Supplemental Nutrition Program for Women, Infants and Ch

176 The Special Supplemental Nutrition Program for Women, Infants, and C

177 ight loss program in addition to the Special Supplemental Nutrition Program for Women, Infants, and C

178 In general, participants in the Special Supplemental Nutrition Program for Women, Infants, and C

179 There is evidence that the Special Supplemental Nutrition Program for Women, Infants, and C

180 ivity and impaired bronchodilation following supplemental O(2) (hyperoxia) in early life, making it i

181 tegory (level IV) with prolonged exposure to supplemental O2 (>=120 days) that has the highest risk o

182 high-concentrate total mixed ration with no supplemental oil.

183 fiable Diseases Surveillance System and from supplemental outbreak data through direct communications

184 The HR for death in patients with supplemental oxygen >2 L/min at diagnosis was 6.18 ([1.3

185 At baseline, 22/23 were receiving supplemental oxygen (3/23 high flow, 7/23 mechanical ven

186 her were randomly assigned to receive either supplemental oxygen (6 liters per minute for 6 to 12 hou

187 metry (66.5%), other monitoring (59.6%), and supplemental oxygen (62.0%)-were noninvasive.

188 oalbuminemia, low creatinine, and the use of supplemental oxygen (all P < 0.05).

189 ding to the level of respiratory support and supplemental oxygen administered at 36 weeks' postmenstr

190 Supplemental oxygen administration abrogated the oscilla

191 bronchiolitis who were not receiving active supplemental oxygen administration, monitoring with cont

192 talization with bronchiolitis without active supplemental oxygen administration.

193 bronchiolitis who were not receiving active supplemental oxygen administration.

194 re clinical worsening and discontinuation of supplemental oxygen among patients who had been receivin

195 tiviral drug remdesivir and, when indicated, supplemental oxygen and glucocorticoids.

196 Some patients required supplemental oxygen and had variable clinical outcomes f

197 se was summarized, including requirement for supplemental oxygen and intensive care and use of empiri

198 f oxygen/respiratory support (RS) (receiving supplemental oxygen and/or positive-pressure RS); among

199 Infants requiring mechanical support but no supplemental oxygen at 36 weeks' postmenstrual age had s

200 duces 28-day mortality in patients requiring supplemental oxygen compared with usual care (21.6% vs 2

201 This study aimed to investigate whether supplemental oxygen during hypothermic machine perfusion

202 e short- and long-term effects of early-life supplemental oxygen exposure.

203 Supplemental oxygen for patients with resting hypoxemia

204 s C), pulmonary infiltrates, or the need for supplemental oxygen in order to maintain an oxygen satur

205 Supplemental oxygen in patients with resting hypoxemia p

206 o Correction of stroke-induced hypoxia using supplemental oxygen in vivo lowered Glu levels as measur

207 d viral pneumonia, of whom 20 (20%) required supplemental oxygen including 12 (12%) invasive mechanic

208 Although supplemental oxygen is required to promote survival of s

209 firmed Covid-19 who were receiving either no supplemental oxygen or a maximum of 4 liters per minute

210 with preterm birth, time after weaning from supplemental oxygen or flow, apnea or cyanosis during th

211 se patients, none of whom were receiving any supplemental oxygen or nasal cannula flow, was 46% (95%

212 osis of RSV infection during which </=2 L of supplemental oxygen per minute was received.

213 For 3 of the 5 patients, fever resolved and supplemental oxygen requirement was reduced within 3 day

214 s time to recovery (hospital discharge or no supplemental oxygen requirement) from 15 to 11 days.

215 n his pulmonary function tests, cessation of supplemental oxygen requirements and near normalization

216 Supplemental oxygen substantially reduced intermittent h

217 re unit (RR, 3.9; 95% CI, 3.4-4.5), need for supplemental oxygen therapy (RR, 3.4; 95% CI, .5-21.1),

218 entation, monitoring, and discontinuation of supplemental oxygen therapy.

219 ration less than 92% on room air or need for supplemental oxygen to achieve oxygen saturation of 92%

220 owing a 20-minute wash in period of low flow supplemental oxygen to normalize arterial oxygen saturat

221 s that develop in preterm infants exposed to supplemental oxygen to prevent respiratory failure.

222 Acute or pre-existing renal disease, supplemental oxygen upon hospitalization, and admission

223 Supplemental oxygen use was lower in patients with possi

224 t 36 weeks' postmenstrual age, regardless of supplemental oxygen use.

225 ver trial assessing the effects of overnight supplemental oxygen versus air (sham) on morning BP, aft

226 Supplemental oxygen virtually abolished the BP rise afte

227 Supplemental oxygen virtually abolished the rise in morn

228 The median time to discontinuation of supplemental oxygen was 5.0 days (95% CI, 3.8 to 7.6) in

229 A drop in oxygen saturation that required supplemental oxygen was the most common SAE.

230 Five individuals requiring supplemental oxygen were treated with lopinavir-ritonavi

231 in the intensive care unit; 46.8% receiving supplemental oxygen without positive pressure; 11.5% rec

232 , or not in intensive care and not requiring supplemental oxygen) and age (<18 years and >=18 years).

233 haler or nebulizer treatments, 41 (22%) used supplemental oxygen, and 24 (13%) were admitted as an in

234 ministered (intravenous fluids, antibiotics, supplemental oxygen, and respiratory medications), trans

235 i defined as one of: mechanical ventilation, supplemental oxygen, bronchodilators or steroids at 28 d

236 plemental oxygen, hospitalised not requiring supplemental oxygen, discharged but unable to resume nor

237 n intensive care, hospitalised but requiring supplemental oxygen, hospitalised not requiring suppleme

238 The use of supplemental oxygen, need for assistive devices, and job

239 ops, respiratory distress at birth, need for supplemental oxygen, neonatal ventilator use, and neonat

240 re unit, not in intensive care but requiring supplemental oxygen, or not in intensive care and not re

241 prevalent in preterm babies with a need for supplemental oxygen, resulting in impaired lung developm

242 roven/probable LRTI had a median of 16 fewer supplemental oxygen-free days than those presenting with

243 Supplemental oxygen-free days were defined as any day wh

244 ater than 24 breaths/min, and 27.8% received supplemental oxygen.

245 g the previous year or the prescribed use of supplemental oxygen.

246 patients hospitalized with COVID-19 require supplemental oxygen.

247 lly scarce resources such as antibiotics and supplemental oxygen.

248 ildren with bronchiolitis who do not require supplemental oxygen.

249 ts in the placebo group were still receiving supplemental oxygen.

250 xygen or a maximum of 4 liters per minute of supplemental oxygen.

251 Six individuals (33%) required supplemental oxygen; of these, 2 required intensive care

252 aphy (all of whom were symptomatic) required supplemental oxygenation and inpatient treatment.

253 Supplemental oxygenation of the standard hypothermic mac

254 ith findings of pulmonary infection required supplemental oxygenation, and they received only symptom

255 The supplemental PDF serves as a practical guide, with compl

256 proliferative and mitochondrial responses to supplemental PEMFs, whereas small interfering RNA gene s

257 Boosting these functions by supplemental pharmacological engagement of the endotheli

258 strative claims from commercial and Medicare Supplemental plans (2001-2014), we compared risk of MI i

259 ith employer-sponsored insurance or Medicare supplemental plans between 2011 and 2018, before and aft

260 plans; 8 per 1000 among patients in Medicare Supplemental plans).

261 strative claims from commercial and Medicare Supplemental plans, data from the GI Quality Improvement

262 ate the effects of the addition of different supplemental plant oils to a high concentrate diet on ru

263 0.08; 95% CI, -0.51 to 0.36) or the Medicare Supplemental population (weighted RD per 1000, -0.45; 95

264 tients in the dexmedetomidine group received supplemental propofol (64% of patients), midazolam (3%),

265 potassium than soy and casein proteins, as a supplemental protein source for MHD patients.

266 in exposure of myoblasts to 1.5 mT amplitude supplemental pulsed magnetic fields (PEMFs) accentuated

267 east magnetic resonance imaging (AB-MR) as a supplemental screening test in women with dense breasts.

268 breast magnetic resonance (MR) imaging as a supplemental screening tool in women at average risk for

269 creening examination and in possible need of supplemental screening.

270 lert testing at 32.5 degrees C paired with a supplemental SDA plate as an acceptable alternative to t

271 ditional ten articles were obtained from the supplemental search.

272 to that in the usual-care group and required supplemental sedatives to achieve the prescribed level o

273 s drug administration (MDA) and, in 2017, on supplemental snail control.

274 Allograft mice receiving supplemental sodium acetate exhibited similar protection

275 edit extrahepatic tissues via addition of a supplemental SORT molecule.

276 ve isotope that does not require an external supplemental source.

277 x, race/ethnicity) and dietary compared with supplemental sources of choline intake were also investi

278 is and set a stage for future development of supplemental strategies for the management of CUD-associ

279 ss and organic-S accumulation in response to supplemental sulfate, whereas Sarcocornia fruticosa (eco

280 Using nontreponemal supplemental testing, the sensitivity improved to a pool

281 avoid predation improved when they received supplemental TH.

282 expansion was not increased by adding either supplemental TNF ligand or a cross-linking reagent, sugg

283 ody-based techniques are being introduced as supplemental tools.

284 Supplemental training sets contained 199-568 CT images d

285 stay, the percentage of infants who required supplemental treatment with phenobarbital, and safety.

286 However, patients who develop GVHD require supplemental treatment.

287 agulation (PRP) had a higher risk to undergo supplemental treatments (hazard ratio 1.5 [95% confidenc

288 A Supplemental Tutorial provides examples of how to analyz

289 New supplemental US Food and Drug Administration approvals,

290 reduction in susceptible individuals due to supplemental vaccination campaigns is frequently below t

291 We further quantified the impact of supplemental vaccination campaigns on the reduction of s

292 The supplemental value of FFQ data was considered by examini

293 orted a randomized trial demonstrating daily supplemental vitamin C to pregnant smokers significantly

294 ants of pregnant smokers randomized to daily supplemental vitamin C would have improved forced expira

295 an HL-xenograft animal model, we showed that supplemental vitamin D (dietary supplement, cholecalcife

296 Moderate supplemental vitamin D intake was associated with decrea

297 serum 25-hydroxyvitamin D [25(OH)D] levels, supplemental vitamin D use, and breast cancer incidence

298 For supplemental vitamin D, we observed possible inverse ass

299 n-3 FAs but no clear CVD risk reduction from supplemental vitamin D.

300 completed 8 wk of supervised RT and consumed supplemental whey protein.